Leukemia Research
Volume 25, Issue 9 , Pages 783-791, 1 September 2001

Poor prognosis acute myelogenous leukemia: 3—biological and molecular biological changes during remission induction therapy

Rush Cancer Institute, 1725 West Harrison Street, Suite 809, Chicago, IL 60612 USA

Received 10 April 2000; accepted 21 January 2001.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0145-2126(01)00032-7

Leukemia Research
Volume 25, Issue 9 , Pages 783-791, 1 September 2001

Article Tools

* Image Usage & Resolution